Dr. Horacio Kaufmann is the Axelrod Professor of Neurology, Professor of Medicine and Pediatrics, Chief of the Division of Autonomic Disorders, and Program Director for the Autonomic Fellowship program, all at New York University Grossman School of Medicine. He is also the Director of the Dysautonomia Center at NYU Langone Health. Dr. Kaufmann has mentored over 30 fellows and post-docs in clinical autonomic neurology.

His research and clinical career have been focused on genetic and neurodegenerative disorders affecting autonomic neurons, with particular emphasis on the synucleinopathies, including Pure Autonomic Failure, Parkinson disease and multiple system atrophy (MSA). He was the PI of the Natural History Study of the Synucleinopathies (NHSS), a multicenter prospective study running for ten years funded by the NINDS, Dr. Kaufmann has established an international collaboration of 22 centers in America, Europe and Asia that shares data and research projects and supports the careers of young clinical scientists. He was co-chair of the task force of the Movement Disorders Society to update the diagnostic criteria of MSA. He is currently the PI of the NINDS funded Clinical Trial Readiness in MSA, an international, multicenter, prospective, observational study to develop a novel clinical outcome assessment and biomarkers for MSA. He was one of the principal investigators of the clinical trials that led to the approval of the two drugs (midodrine and droxidopa) currently used for the treatment of neurogenic orthostatic hypotension. Dr. Kaufmann described the autonomic phenotype of Familial Dysautonomia (HSAN type 3) and dramatically changed clinical management of these patients. 

He is Editor in Chief of Clinical Autonomic Research, the preeminent subspecialty journal published by Springer-Nature.